3 articles
Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing power of semaglutide — the active ingredient in Ozempic — without the...
Millions of Seniors Gain Access to Affordable Weight-Loss Medications In a historic shift in public health policy, Medicare has officially begun covering GLP-1 weight-loss drugs...
A major new study involving more than 110,000 women has found that popular GLP-1 weight-loss and diabetes drugs — including Ozempic, Wegovy, Mounjaro, and Zepbound...